p53 and p21WAF1/CIP1 overexpression at the invasive front of lower lip squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 36, Issue 2, 2007, Pages 88-92

  Horta, Martinho Campolina Rebello ^a   De Assis, Luis Alpino Prandini ^b   De Souza, Antonio Francisco ^b,c   De Araújo, Vera Cavalcanti ^d   Gomez, Ricardo Santiago ^c   Aguiar, Maria Cássia Ferreira ^c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Mario Penna Hospital   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cyclin kinase inhibitor p21; Lip cancer; Squamous cell carcinoma; Tumor suppressor protein p53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P53; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA BINDING PROTEIN; PDRG1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOWER LIP SQUAMOUS CELL CARCINOMA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; CHEMISTRY; ENZYMOLOGY; LIP TUMOR; MIDDLE AGED; NONPARAMETRIC TEST;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIP NEOPLASMS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 33846148642     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00495.x     Document Type: Article

References (45)

1. Krolls SO, Hoffman S. Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14.235 cases by age, sex, and race of patients. J Am Dent Assoc 1976; 92: 571-4.
2. Douglas CW, Gammon MD. Reassessing the epidemiology of lip cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1984; 57: 631-42.
3. De Vissher JGAM, Van Der Waal I. Etiology of cancer of the lip: a review. Int J Oral Maxillofac Surg 1998; 27: 199-203.
4. Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of lip cancer: a review of global incidence and etiology. Oral Dis 1999; 5: 185-95.
5. Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a better prognostic indicator than Broder's grading in oral squamous cell carcinomas. J Oral Pathol Med 1989; 18: 432-7.
6. Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 1992; 166: 375-81.
7. Bryne M, Jenssen N, Boysen M. Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Archiv 1995; 427: 277-81.
8. Odell EW, Jani P, Ahluwalia SM, Levison, DA. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas: the importance of the pattern of invasion. Cancer 1994; 74: 789-94.
9. Piffkò J, Bànkfalvi A, Öfner D, et al. In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinomas. Virchows Archiv 1996; 429: 229-34.
10. Piffkò J, Bànkfalvi A, Öfner D, et al. Prognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumor front of oral squamous cell carcinomas. Br J Cancer 1997; 75: 1543-6.
11. Bànkfalvi A, Piffkò, J. Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med 2000; 29: 291-98.
12. Kurokawa H, Zhang M, Matsumoto S, et al. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med 2005; 34: 329-33.
13. Peters G, Vousden KH. Oncogenes and tumour suppressors. New York: Oxford University Press, 1997.
14. Bray SE, Schorl C, Hall PA. The challenge of p53: linking biochemistry, biology, and patient management. Stem Cells 1998; 16: 248-60.
15. Nylander K, Dabelsteen E, Hall PA. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000; 29: 413-25.
16. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-77.
17. EL-Deiry WS, Tokino T, Veiculescu VE, et al. WAF 1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25.
18. Yeudall WA, Jakus J. Cyclin kinase inhibitors add a new dimension to cell cycle control. Eur J Cancer 1995; 31B: 291-8.
19. waf1. Oral Oncol 2000; 36: 3-7.
20. WAF1/Cip1: more than a break to the cell cycle? BBA-Rev Cancer 2000; 1471: M43-56.
21. Yamazaki Y, Chiba I, Hirai A, et al. Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma. Oral Oncol 2003; 39: 163-9.
22. Carlos DE, Vicente J, Junquera Gutierrez LM et al. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Head Neck 2004; 26: 22-30.
23. Kozomara R, Jovic N, Magic Z, Brankovic-Magic M, Minic V. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival. J Craniomaxillofac Surg 2005; 33: 342-8.
24. Agarwal S, Mathur M, Shukla NK, Ralhan R. Expression of cyclin dependent kinase inhibitor p21 (waf1/cip1) in premalignant and malignant oral lesions: relationship with p53 status. Oral Oncol 1998; 34: 353-60.
25. Tatemoto Y, Osaki T, Yoneda K, Yanamoto T, Ueta E, Kimura T. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy. Pathol Res Pract 1998; 194: 821-30.
26. WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med 2005; 34: 274-9.
27. Piffkò J, Bànkfalvi A, Tory K, et al. Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas. Head Neck 1998; 20: 8-15.
28. Kurokawa H, Zhang M, Matsumoto S, et al. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med 2005; 34: 602-7.
29. Ostwald C, Gogacz P, Hillmann T, et al. p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity. Int J Cancer 2000; 88: 82-6.
30. Berner A, Holm R, Naess A, Hjortdal O. p53 expression in squamocellular carcinomas of the lip. Anticancer Res 1993; 13: 2421-4.
31. Crosthwaite N, Teale D, Franklin C, Foster GA, Stringer BM. p53 protein expression in malignant, pre-malignant and non-malignant lesions of the lip. J Clin Pathol 1996; 49: 648-53.
32. De Rosa I, Staibano S, Lo Muzio L et al. Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis. J Oral Pathol Med 1999; 28: 252-8.
33. Fabrrocini G, Russo N, Pagliuca MC, et al. p53, cyclin-D1, PCNA, AgNOR expression in squamous cell cancer of the lip: a multicenter study. Photodermatol Photoimmunol Photomed 2000; 16: 172-7.
34. Van Oijen MGCT, Tilanus MGJ, Medema RH, Slootweg PJ. Expression of p21(Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med 1998; 27: 367-75.
35. Yook JI, Kim J. Expression of p21 WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinoma. Oral Oncol 1998; 34: 183-203.
36. Shin DM, Charuruks N, Lippman SM, et al. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis. Cancer Epidemiol Biomarkers Prev 2001; 10: 603-9.
37. Osaki T, Kimura T, Tatemoto Y, Dapeng L, Yoneda K, Yanamoto T. Diffuse mode of tumor cell invasion and expression of mutant p53 protein but not of p21 protein are correlated with treatment failure in oral carcinoma and their metastatic foci. Oncology 2000; 59: 36-43.
38. Cardinali M, Jakus J, Shah S, Ensley JF, Robbins KC, Yeudall WA. p21 (WAF1/CIP1) retards the growth of human squamous cell carcinomas in vivo. Oral Oncol 1998; 34: 211-8.
39. Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002; 179: 1-14.
40. Erber R, Klein W, Andl T, et al. Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Int J Cancer 1997; 74: 383-9.
41. Ng IOL, Lam KY, NG M, Regezi JA. Expression of p21/waf 1 in oral squamous cell carcinomas - correlation with p53 and mdm2 and cellular proliferation index. Oral Oncol 1999; 35: 63-9.
42. Regezi JA, Dekker NP, McMillan A, et al. p53, p21, pRb, and mdm2 proteins in tongue carcinoma from patients <35 versus >75 years. Oral Oncol 1999; 35: 379-83.
43. Yuen PW, Chow V, Choy J, Lam KY, HO WK, Wei WI. The clinicopathologic significance of p53 and p21 expression in the surgical management of lingual squamous cell carcinoma. Am J Clin Pathol 2001; 116: 240-55.
44. Yanamoto S, Kawasaki G, Yoshitomi I, Mizuno A. p53, mdm2 and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 593-600.
45. Liu CJ, Chang KW, Chao SY, et al. The molecular markers for prognostic evaluation of areca-associated buccal squamous cell carcinoma. J Oral Pathol Med 2004; 33: 327-34.